Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Roflumilast vs Intralesional Corticosteroids in Alopecia Areata
NCT07174011Phase 4Completed
- Sponsor
- Cairo University
- Start
- Jan 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roflumilast in alopecia areata, sponsored by Cairo University. Started Jan 2025; status: completed.
02
Drugs
roflumilast
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07174011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07174011.